|
|
| Research article summary (published 30 Mar 1999): |
Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
Full Abstract
OBJECTIVES: In this study we examined changes in attention-deficit hyperactivity disorder behaviors and motor and vocal tics during withdrawal from long-term maintenance therapy with stimulant medication. METHODS: Subjects were 19 children with attention-deficit hyperactivity disorder and chronic tic disorder who had received methylphenidate (n = 17) or dextroamphetamine (n = 2) for a minimum of 1 year. Children were switched to placebo under double-blind conditions. Treatment effects were assessed by using direct observations of child behavior in a simulated (clinic-based) classroom and behavior rating scales completed by parents and clinician. RESULTS: There was no change (group data) in the frequency or severity of motor tics or vocal tics during the placebo condition compared with maintenance dose of stimulant medication (ie, no evidence of tic exacerbation while receiving medication or of a withdrawal reaction). There was no evidence of tic exacerbation in the evening as a rebound effect. Treatment with the maintenance dose was also associated with behavioral improvement in attention-deficit hyperactivity disorder behaviors, indicating continued efficacy. CONCLUSIONS: Abrupt withdrawal of stimulant medication in children receiving long-term maintenance therapy does not appear to result in worsening of tic frequency or severity. Nevertheless, these findings do not preclude the possibility of drug withdrawal reactions in susceptible individuals.
Author information
Author/s: Nolan, E E (EE); Gadow, K D (KD); Sprafkin, J (J);
Affiliation: Department of Psychiatry and Behavioral Science, SUNY at Stony Brook, Stony Brook, New York 11794-8790, USA.
Grants: MH 45358 (Agency:NIMH NIH HHS)
Journal and publication information
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal: Pediatrics (Pediatrics), published in UNITED STATES. (Language: eng)
Reference: 1999-Apr; vol 103 (issue 4 Pt 1) : pp 730-7
Dates: Created 1999/04/15; Completed 1999/04/15; Revised 2007/11/14;
PMID: 10103294, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- [Methylphenidate of retard forms in children and adolescents with ADHD - an overview]
19 Dec 2007 - Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
26 Oct 2005 - Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
28 Feb 2004 - Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.
30 May 1998 - Psychostimulants and psychiatrists: the Trent Adult Psychiatry Psychostimulant Survey.
28 Feb 2000 - Slowing of growth in height and weight on stimulants: a characteristic pattern.
30 Mar 2003 - Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
30 Dec 2003 - Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder.
29 Nov 2004 - Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
30 Jan 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.